Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:TG 16:0_18:1_24:4)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST003988 AN006569 Lipid and cell cycling perturbations driven by the HDAC inhibitor romidepsin render liver cancer vulnerable to RTK targeting and immunologically active Cultured cells Human Cancer CNRS LC-MS
ST003716 AN006097 Lipidomics analysis of mice treated with tung or safflower oil by oral gavage. Cultured cells Mouse Cancer University of Chicago LC-MS
ST003637 AN005973 lomitapide effects on lipidomics Pancreas Human Cancer Pennsylvania State University LC-MS
  logo